A new survey reveals the majority of the general public thinks more cancer research is in order, but many are reluctant to pitch in to the effort financially.
Cancer touches nearly every person walking the planet, whether it is as the loved one of a patient themselves. With so many lives impacted by the disease, the producers of a recent survey were interested in gauging the public’s opinion on cancer research.
Nuformix plc (LON:NFX) is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology using drug repurposing.
